Selank for ADHD: What Does Research Suggest?
Selank has garnered interest from researchers and the nootropic community due to its reported effects on anxiety regulation, cognitive function, and neurochemical balance. Although Selank is not approved as a treatment for Attention-Deficit/Hyperactivity Disorder (ADHD), several experimental and clinical studies suggest that it may interact with biological pathways related to attention, executive functions, working memory, and cognitive performance [1–4].
ADHD is a complex neurodevelopmental disorder characterized by changes in attention control, executive functions, emotional regulation, and neurotransmitter signaling. Currently used therapies primarily focus on dopaminergic and noradrenergic pathways. In contrast, Selank appears to act as a regulatory neuropeptide that simultaneously affects multiple systems, including GABAergic signaling, endogenous opioid pathways, mechanisms related to neuroplasticity, and gene expression networks [1].
The phrase "more and more often" „Selank for ADHD” appears in the context of research on neuropeptides that can support concentration, emotional regulation, and cognitive performance.
Can Selank Improve Concentration?
Many people interested in Selank wonder if it can support concentration and focus. Although there are currently no direct studies conducted on individuals with ADHD, existing data points to several mechanisms that could theoretically contribute to improved attention functions.
Research suggests that Selank exhibits nootropic properties and may support cognitive functions without causing significant sedation or memory impairment [1]. Experimental studies have shown that Selank acts as a positive allosteric modulator of GABA receptors, which may help to limit excessive stress responses and reduce anxiety-related cognitive impairments [1].
Since anxiety and cognitive overload can worsen concentration difficulties, limiting stress-related signaling may indirectly improve focus and clarity of thought. In human studies, psychostimulant and anti-asthenic effects have also been noted in patients with generalized anxiety disorder and neurasthenia, suggesting potential benefits for mental energy and cognitive performance [2].
However, it should be emphasized that no randomized clinical trials have been conducted evaluating Selank for core ADHD symptoms such as inattention, impulsivity, or hyperactivity.
Selank and Cognitive Functions
Several studies suggest that Selank may support cognitive functions through mechanisms related to neuroplasticity. In animal studies, intranasal administration of Selank altered the expression of brain-derived neurotrophic factor (BDNF) in the hippocampus, a protein involved in synaptic plasticity, learning, memory formation, and neuronal adaptation [3].
BDNF plays a crucial role in maintaining healthy neural networks and supporting cognitive function. Impaired neuroplasticity is associated with many neuropsychiatric disorders, including ADHD. Although current data do not indicate that Selank directly treats ADHD, its impact on neurotrophic signaling may partially explain the cognitive benefits observed in experimental studies.
Researchers also suggest that Selank's combined anxiolytic and neuroregulatory action may support cognitive performance under stress without causing the sedative effects typical of traditional anxiolytics [1].
Is Selank a Nootropic?
Selank is often referred to as a nootropic peptide because experimental studies have demonstrated its cognitive-enhancing and neuroprotective properties. Unlike classical stimulants, which primarily increase catecholamine activity, Selank appears to function as a regulatory peptide influencing multiple neurotransmitter systems and neuroplasticity-related pathways simultaneously [1].
Experimental and clinical studies suggest that Selank may support emotional regulation, stress resilience, cognitive performance, clarity of thought, learning processes, memory formation, mechanisms related to neuroplasticity, and the maintenance of normal neuron function [1–3].
Despite this, current evidence remains limited, and further research is needed to determine whether these effects translate into significant benefits for individuals with ADHD.
Does Selank work for ADHD?
Currently, there is insufficient scientific evidence to conclude that Selank is an effective treatment for ADHD.
No large clinical trials have evaluated Selank in children or adults with ADHD. Current findings suggest that Selank may support cognitive performance and reduce anxiety-related cognitive impairments, but its direct impact on core ADHD symptoms remains unknown.
The most scientifically justified conclusion is that Selank has properties that could theoretically support certain cognitive and emotional functions relevant to ADHD; however, dedicated clinical studies are necessary before drawing conclusions about its efficacy.
Can Selank Help with Depression?
Research on Selank and Depression
Depression is a multifactorial disorder involving complex interactions between neurotransmitters, neuroplasticity, stress regulation, inflammation, and brain network function. Since Selank affects several of these systems, researchers have analyzed whether the peptide may exhibit mood-boosting properties.
Current evidence suggests that Selank exhibits anxiolytic, neuroprotective, and cognitive-regulating effects; however, direct evidence supporting its use as an antidepressant remains limited [1–4].
Does Selank help with depression?
Several study results suggest that Selank may affect biological pathways often disrupted in depression.
First, Selank has been shown to modulate GABA receptor activity through positive allosteric mechanisms [1]. Disruption of GABAergic signaling is associated with both anxiety and depressive disorders, and enhancing inhibitory neurotransmission may support emotional stability.
Secondly, Selank affects endogenous opioid peptides by inhibiting enzymes that break down enkephalins and prolonging their activity [4]. These naturally occurring peptides play an important role in emotion regulation, stress adaptation, and reward processing, which can influence mood.
Thirdly, experimental studies have shown that Selank regulates BDNF expression in the hippocampus [3]. Reduced BDNF activity is associated with impaired neuroplasticity and depression, prompting researchers to hypothesize that interventions affecting neurotrophic pathways may support emotional well-being.
What do studies show in humans?
Clinical trials on Selank have primarily been conducted in individuals with generalized anxiety disorder and neurasthenia, not in patients with major depressive disorder [2]. These studies have demonstrated anxiolytic effects and psychostimulating and anti-asthenic properties, suggesting an improvement in mental fatigue and overall emotional functioning.
However, these results should not be interpreted as evidence for the treatment of clinical depression.
No large randomized clinical trials have been conducted evaluating Selank for the treatment of major depression, dysthymia, or treatment-resistant depression.
Current Scientific Proposal
Available data indicate that Selank affects several biological systems involved in mood regulation, including GABAergic signaling, endogenous opioid activity, neuroplasticity, and stress adaptation [1–4]. These mechanisms can theoretically support emotional resilience and mental well-being.
However, the current results are preliminary, and there is insufficient clinical evidence to conclude that Selank is an effective treatment for depression.
Does Selank Help with Sleep?
Selank and Sleep Regulation
Sleep and anxiety are closely related. Chronic stress and excessive arousal can make it difficult to fall asleep, stay asleep, and reduce sleep quality. Since Selank has shown anxiolytic and stress-response regulating effects, many people wonder if it can also support sleep.
Current data suggest that Selank may indirectly promote better sleep by improving emotional regulation and reducing anxiety-related overarousal, although direct studies on sleep remain limited [1–4].
Can Selank help you fall asleep?
Unlike classic sedatives, Selank does not appear to act through general central nervous system depression.
Experimental studies have shown that Selank modulates GABA receptor activity through positive allosteric mechanisms [1]. GABA is the primary inhibitory neurotransmitter in the brain and plays a crucial role in relaxation and sleep regulation. By influencing GABAergic signaling without inducing overt sedation, Selank may help normalize states of excessive psychological and physiological arousal.
Human studies have also shown that Selank reduces anxiety symptoms while exhibiting psychostimulating and anti-asthenic effects, rather than causing excessive drowsiness or sedation [2].
This distinction is important because any improvement in sleep quality may stem from reduced anxiety and better emotional regulation, rather than from a direct hypnotic effect.
Does Selank Improve Sleep Quality?
Reviews of research on age-related hormonal changes, sleep, and cognitive function highlight a close relationship between neuroendocrine regulation, brain function, and sleep quality [5]. As Selank affects several neuroregulatory systems involved in emotional processing and neuroplasticity, researchers suggest that its anxiolytic properties may contribute to improved sleep outcomes.
Some people have reported improvements in sleep quality after reducing anxiety and excessive mental activity, however, these observations are anecdotal.
Currently, no large randomized clinical trials have assessed objective sleep parameters such as sleep onset latency, sleep efficiency, total sleep time, or sleep architecture after Selank administration.
Is Selank a sleep peptide?
Based on available evidence, Selank should not be considered a peptide that directly induces sleep.
Current research, however, suggests that Selank may indirectly support sleep by reducing anxiety and stress-related overstimulation, modulating GABAergic neurotransmission, supporting emotional regulation, and promoting neurochemical balance conducive to relaxation [1–4].
Further clinical studies are needed to determine if these effects translate to a measurable improvement in sleep quality or sleep disorders.
Disclaimer
The content is for educational and informational purposes only. Selank remains a research peptide in many countries, and a significant portion of available data comes from preclinical and early human studies. While published research suggests Selank may affect cognitive function, emotional regulation, neuroplasticity, and stress-related pathways, there is currently insufficient evidence to confirm its efficacy in treating ADHD, depression, or sleep disorders.
For research purposes only: The Selank products offered by Semax Polska are intended solely for laboratory and scientific research. They are not approved for human consumption, medical use, diagnosis, treatment, or prevention of disease. Additional, well-designed clinical trials involving humans are needed to fully characterize Selank’s therapeutic potential and long-term safety profile.
References
[1] Vyunova, T. V., Andreeva, L., Shevchenko, K., & Myasoedov, N. F. (2018). Peptide-Based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein and Peptide Letters, 25(10), 914–923. https://doi.org/10.2174/0929866525666180925144642
[2] Zozulia, A. A., Neznamov, G. G., Siuniakov, T. S., Kost, N. V., Gabaeva, M. V., Sokolov, O. Y., Serebriakova, E. V., Siranchieva, O. A., Andriushenko, A. V., Telesheva, E. S., Siuniakov, S. A., Smulevich, A. B., Myasoedov, N. F., & Seredenin, S. B. (2008). Efficacy and Possible Mechanisms of Action of a New Peptide Anxiolytic Selank in the Therapy of Generalized Anxiety Disorders and Neurasthenia. Journal of Neurology and Psychiatry named after S.S. Korsakov, 108(4), 38–48. https://pubmed.ncbi.nlm.nih.gov/18454096/
[3] Levitskaya, N. G., Andreeva, L. A., Mezentseva, M. V., Shapoval, I. M., Podchernyaeva, R. Y., Shcherbenko, V. E., Potapova, L. A., Russu, L. I., Ershov, F. I., & Myasoedov, N. F. (2010). Intranasal Administration of the Peptide Selank Regulates BDNF Expression in Rat Hippocampus In Vivo. Doklady Biological Sciences, 431, 79–82. Available from: https://www.researchgate.net/profile/Natalia-Levitskaya/publication/23306196_Intranasal_administration_of_the_peptide_Selank_regulates_BDNF_expression_in_the_rat_hippocampus_in_vivo
[4] Zozulya, A. A., Kost, N. V., Sokolov, O. Y., Gabaeva, M. V., Grivennikov, I. A., Andreeva, L. N., Zolotarev, Y. A., Ivanov, S. V., Andryushchenko, A. V., Myasoedov, N. F., & Smulevich, A. B. (2001). The Inhibitory Effect of Selank on Enkephalin-Degrading Enzymes as a Possible Mechanism of Its Anxiolytic Activity. Bulletin of Experimental Biology and Medicine, 131(4), 315–317. https://doi.org/10.1023/A:1017979514274
[5] Vitiello, M. V., Schwartz, R. S., Moe, K. E., Mazzoni, G., & Merriam, G. R. (2001). Treating Age-Related Changes in Somatotropic Hormones, Sleep, and Cognition. Dialogues in Clinical Neuroscience, 3(3), 229–236. https://doi.org/10.31887/DCNS.2001.3.3/mvvitiello